• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problems Fracture (1260); Unexpected Therapeutic Results (1631)
Patient Problems Unspecified Infection (1930); Movement Disorder (4412)
Event Date 10/31/2023
Event Type  Injury  
Event Description
It was reported that the deep brain stimulation (dbs) patient will undergo a lead revision procedure to address a possible infection or lead fracture.Despite multiple good faith efforts, boston scientific has been unable to obtain additional information regarding the intervention provided, product information, confirmation of lead fracture and or infection, patient outcome, and device return outcome.
 
Event Description
It was reported that the deep brain stimulation (dbs) patient will undergo a lead revision procedure to address a possible infection or lead fracture.Despite multiple good faith efforts, boston scientific has been unable to obtain additional information regarding the intervention provided, product information, confirmation of lead fracture and or infection, patient outcome, and device return outcome.Additional information was received indicating the reason for the lead replacement was due to poor positioning of the lead wherein it was no longer proving sufficient therapy to address the patients symptoms.It was also indicted that there was no presence of a lead fracture or infection.
 
Event Description
It was reported that the deep brain stimulation (dbs) patient will undergo a lead revision procedure to address a possible infection or lead fracture.Despite multiple good faith efforts, boston scientific has been unable to obtain additional information regarding the intervention provided, product information, confirmation of lead fracture and or infection, patient outcome, and device return outcome.Additional information was received indicating the reason for the lead replacement was due to poor positioning of the lead wherein it was no longer proving sufficient therapy to address the patients symptoms.It was also indicted that there was no presence of a lead fracture or infection.Additional information was received indicating the patient was doing well post-operatively and symptoms have improved.The date of the lead replacement procedure was also provided.
 
Event Description
It was reported that the deep brain stimulation (dbs) patient will undergo a lead revision procedure to address a possible infection or lead fracture.Despite multiple good faith efforts, boston scientific has been unable to obtain additional information regarding the intervention provided, product information, confirmation of lead fracture and or infection, patient outcome, and device return outcome.Additional information was received indicating the reason for the lead replacement was due to poor positioning of the lead wherein it was no longer proving sufficient therapy to address the patients symptoms.It was also indicted that there was no presence of a lead fracture or infection.Additional information was received indicating the patient was doing well post-operatively and symptoms have improved.The date of the lead replacement procedure was also provided.Additional information was received indicating that the explanted lead was discarded at the facility and was not returned to bsc.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key18162078
MDR Text Key328425762
Report Number3006630150-2023-07138
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 02/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/20/2023
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7085230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/31/2023
Initial Date FDA Received11/17/2023
Supplement Dates Manufacturer Received11/28/2023
12/26/2023
01/29/2024
Supplement Dates FDA Received12/26/2023
01/24/2024
02/23/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-